EDGAR Filing Documents for 0000950135-08-003725

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0000950135-08-003725

Filing Date

2008-05-15

Accepted

2008-05-15 16:53:09

Documents

Period of Report

2008-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	RXI PHARMACEUTICALS CORPORATION	b69733rxe10vq.htm	10-Q	136765
2	EX-31.1 SECTION 302 CERTIFICATION OF THE CEO	b69733rxexv31w1.htm	EX-31.1	7744
3	EX-31.2 SECTION 302 CERTIFICATION OF THE CFO	b69733rxexv31w2.htm	EX-31.2	8035
4	EX-32.1 SECTION 906 CERTIFICATION OF THE CEO & CFO	b69733rxexv32w1.htm	EX-32.1	5380
	Complete submission text file	0000950135-08-003725.txt		159254

Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605

Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861

RXI PHARMACEUTICALS CORP (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 08838714
SIC: 2834 Pharmaceutical Preparations